基于灰阶与彩色多普勒超声的甲状腺结节新影像报告与数据系统
本研究回顾性与前瞻性纳入4家医院2932例患者共3940个甲状腺结节,基于放射状血流与灰阶超声特征构建并验证基线超声甲状腺影像报告与数据系统(BUS TI-RADS)。BUS TI-RADS在训练集、内部验证集、外部验证集及前瞻性验证集的AUC分别为0.96、0.93、0.91和0.95,均高于ACR TI-RADS与C-TIRADS,且活检率(4.1%)与假阴性率(18.1%)更低。
要点
- 放射状血流是甲状腺结节恶性的独立预测因子,被纳入BUS TI-RADS。
- BUS TI-RADS在各验证集AUC为0.91~0.96,均高于ACR TI-RADS与C-TIRADS。
- BUS TI-RADS活检率4.1%、假阴性率18.1%,低于ACR TI-RADS(31.2%、20.9%)与C-TIRADS(33.1%、58.5%)。
核心结论
- BUS TI-RADS依据放射状血流与灰阶超声特征的简化回归系数构建,诊断性能优异,可减少不必要的活检并降低漏诊恶性肿瘤率。
研究设计与样本
- 回顾性与前瞻性纳入4家医院2018年1月至2023年11月患者,共2932例(女2153例,年龄42.83±11.71岁;男779例,年龄42.36±11.78岁)3940个结节(恶性2831个、良性1109个)。
关键影像表现/征象
- BUS TI-RADS纳入的超声特征包括成分、回声、形态、边缘、可疑甲状腺外侵犯、点状强回声及放射状血流。
诊断标准与关键数值
- BUS TI-RADS训练集AUC为0.96(95%CI:0.95~0.97;P<0.001)。
- BUS TI-RADS内部验证集AUC为0.93(95%CI:0.90~0.97;P<0.001)。
- BUS TI-RADS外部验证集AUC为0.91(95%CI:0.86~0.96;P<0.003)。
- BUS TI-RADS前瞻性验证集AUC为0.95(95%CI:0.93~0.97;P<0.001)。
- BUS TI-RADS活检率4.1%、假阴性率18.1%,低于ACR TI-RADS(31.2%、20.9%)与C-TIRADS(33.1%、58.5%)。
临床应用与阅片要点
- 决策曲线分析显示BUS TI-RADS净获益更高。
- BUS TI-RADS基于放射状血流与灰阶超声特征,可用于评估甲状腺结节恶性风险并辅助减少活检。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To construct and validate a new thyroid imaging reporting and data system (TI-RADS) based on radiating blood flow and grayscale US features.
MATERIALS AND METHODS: This study enrolled patients from 4 hospitals from January 2018 to November 2023 retrospectively and prospectively. All US features associated with malignant thyroid nodules were assessed by multivariable logistic regression to construct baseline US TI-RADS (BUS TI-RADS), which was tested with internal validation set, external validation set and prospective validation set. Additionally, its potential of reducing biopsy was assessed.
RESULTS: There were 2932 patients (2153 female, age: 42.83 ± 11.71; 779 male, age: 42.36 ± 11.78) with 3940 nodules (2831 malignant nodules and 1109 benign nodules). Independent predictive factors included composition, echogenicity, shape, margin, suspicious extrathyroidal extension, punctate echogenic foci, and radiating blood flow. Compared with American College of Radiology (ACR) TI-RADS and Chinese TI-RADS (C-TIRADS), the BUS TI-RADS had higher AUCs of 0.96 (95 % CI: [0.95, 0.97]; P < 0.001), 0.93 ([0.90, 0.97]; P < 0.001), 0.91 ([0.86, 0.96]; P < 0.003) and 0.95 ([0.93, 0.97]; P < 0.001) for the training set, internal validation set, external validation set and prospective validation set respectively. Decision curve analysis demonstrated higher net benefit for the BUS TI-RADS. And the BUS TI-RADS (4.1 %; 18.1 %) had lower percentage of biopsy and false negative rate compared with the ACR TI-RADS (31.2 %; 20.9 %) and C-TIRADS(33.1 %; 58.5 %).
CONCLUSION: BUS TI-RADS was created according to the simplified regression coefficients of radiating blood flow and grayscale ultrasonography features with excellent diagnostic performance and could reduce unnecessary biopsy with lower missed malignancy.
引用
- Wang Z, Huang SS, Zhu YF, et al. A new thyroid imaging reporting and data system for nodules: Based on grayscale and color Doppler ultrasonography. Eur J Radiol. 2024. PMID: 39642408. doi:10.1016/j.ejrad.2024.111866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。